The Pharmacology Center

Filter Your Results

 

News

 

Two-Year ADAPT-DES Data Examine Relationship of IVUS Guidance on DES Outcomes

November 16, 2018 -- Two-year follow-up data from the large-scale ADAPT-DES study assessing dual-antiplatelet therapy with drug-eluting stents (DESs) implanted with intravenou…

OSLER-1 Evaluates Long-Term Safety and Efficacy of Amgen's Repatha

November 12, 2018 -- Amgen announced the presentation of the final report of the OSLER-1 trial at the American Heart Association (AHA) 2018 scientific sessions held November 1…

AHA and ACC Publish 2018 Cholesterol Guidelines

November 10, 2018 -- The American Heart Association (AHA) and American College of Cardiology (ACC) announced the publication of 2018 cholesterol guidelines recommending more p…

REDUCE-IT Trial Evaluates Amarin's Vascepa for Reduction in MACE

November 10, 2018 -- Amarin Corporation plc announced that the results from the REDUCE-IT trial of cardiovascular outcomes of the company's Vascepa (icosapent ethyl) were …

FDA Approves Indication for Xarelto to Reduce Risk of Major CV Events in Patients With Chronic CAD or PAD

October 11, 2018 -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the FDA has approved Xarelto (rivaroxaban) to reduce the risk of major cardiov…

OAC-ALONE Studies Antithrombotic Therapy Beyond 1-Year for Stent Patients With Atrial Fibrillation

September 24, 2018 -- The Cardiovascular Research Foundation (CRF) announced that findings from the first randomized trial of its kind was unable to establish noninferiority o…

Medtronic Begins 1-Month DAPT Clinical Study in the United States and Japan

September 13, 2018 -- Medtronic announced the start of the Onyx ONE Clear study in the United States and Japan. Onyx ONE Clear will evaluate 1-month dual antiplatelet the…

GLOBAL LEADERS Trial Presented at ESC Congress

August 27, 2018 -- The European Society of Cardiology (ESC) announced that findings from the GLOBAL LEADERS trial demonstrated that long-term antiplatelet monotherapy after st…

 

advertisement

2018 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.